IE
DNA icon

Israel Englander’s Ginkgo Bioworks DNA Stock Holding History

Israel Englander’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,500
Closed -$507K – 6255
2023
Q4 		$507K Buy
+7,500
New +$459K ﹤0.01% 4632
2022
Q4 		– Sell
-5,000
Closed -$624K – 6652
2022
Q3 		$624K Buy
+5,000
New +$596K ﹤0.01% 4760

Other funds holding DNA

California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's DNA Position: Q2 2026 in Review

Israel Englander increased its Ginkgo Bioworks (DNA) stake by 31% in Q2 2026, buying an estimated $1.26M and bringing the position to 638,676 shares worth $6.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

Israel Englander first reported a position in DNA in Q3 2021 and has held it in 18 quarters since. The position peaked at $17.5M in Q3 2021. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Israel Englander held 638,676 shares of Ginkgo Bioworks worth $6.33M as of Q2 2026.
  • Israel Englander bought 150,719 Ginkgo Bioworks shares in Q2 2026, an estimated $1.26M.
  • Ginkgo Bioworks made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2769 holding.
  • Israel Englander first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 18 quarters since.
  • Israel Englander's Ginkgo Bioworks position peaked at $17.5M in Q3 2021.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.